$Cocrystal Pharma (COCP.US)$ The new compounds in the public...
$Cocrystal Pharma (COCP.US)$ The new compounds in the publication are exclusively licensed and being developed by cocrystal pharma for COVID-19. K-State Innovations Partners handles commercial technology licensing for the university. https://www.eurekalert.org/pub_releases/2020-08/ksu-nps080320.php
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
